JO2726B1 - Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline - Google Patents

Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline

Info

Publication number
JO2726B1
JO2726B1 JO200752A JOP20070052A JO2726B1 JO 2726 B1 JO2726 B1 JO 2726B1 JO 200752 A JO200752 A JO 200752A JO P20070052 A JOP20070052 A JO P20070052A JO 2726 B1 JO2726 B1 JO 2726B1
Authority
JO
Jordan
Prior art keywords
methylaminoquinazolin
benzoylaminophenyl
dimethoxy
derivatives
optionally substituted
Prior art date
Application number
JO200752A
Other languages
Arabic (ar)
English (en)
Inventor
مايزاكي كازوكي
تاكاسي يوسوتاكا
اسانو اوسامو
شيراتو مانابو
واكيتا هيساشي
سايكي تاكاو
ايشي ناوتو
كوسانو كازوتومي
Original Assignee
ايساي ار و دي مانجمنت كو., ليمتد.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ايساي ار و دي مانجمنت كو., ليمتد. filed Critical ايساي ار و دي مانجمنت كو., ليمتد.
Application granted granted Critical
Publication of JO2726B1 publication Critical patent/JO2726B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JO200752A 2006-02-21 2007-02-20 Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline JO2726B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
JO2726B1 true JO2726B1 (en) 2013-09-15

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200752A JO2726B1 (en) 2006-02-21 2007-02-20 Derivatives 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methylaminokinazoline

Country Status (18)

Country Link
JP (1) JP4778550B2 (el)
KR (1) KR101278852B1 (el)
AT (1) ATE517875T1 (el)
BR (1) BRPI0708098B8 (el)
CY (1) CY1112554T1 (el)
DK (1) DK1992622T3 (el)
ES (1) ES2368089T3 (el)
HK (1) HK1122025A1 (el)
HR (1) HRP20110604T1 (el)
IL (1) IL193322A (el)
JO (1) JO2726B1 (el)
MY (1) MY146275A (el)
NZ (1) NZ569936A (el)
PT (1) PT1992622E (el)
RS (1) RS51969B (el)
RU (1) RU2431632C2 (el)
SI (1) SI1992622T1 (el)
TW (1) TWI404709B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2678477A1 (en) 2007-02-16 2008-08-21 Eisai R&D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
ATE538102T1 (de) 2007-08-17 2012-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung eines chinazolinderivats
EP2202229B1 (en) 2007-08-17 2012-03-14 Eisai R&D Management Co., Ltd. Novel preparation for external use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
MY146275A (en) 2012-07-31
RU2008137654A (ru) 2010-03-27
DK1992622T3 (da) 2011-09-05
SI1992622T1 (sl) 2011-11-30
JPWO2007097317A1 (ja) 2009-07-16
BRPI0708098B8 (pt) 2021-05-25
NZ569936A (en) 2010-07-30
HRP20110604T1 (hr) 2011-09-30
HK1122025A1 (el) 2009-05-08
ES2368089T3 (es) 2011-11-14
JP4778550B2 (ja) 2011-09-21
TW200812980A (en) 2008-03-16
ATE517875T1 (de) 2011-08-15
IL193322A (en) 2014-04-30
BRPI0708098B1 (pt) 2019-08-06
KR101278852B1 (ko) 2013-07-01
TWI404709B (zh) 2013-08-11
IL193322A0 (en) 2009-05-04
CY1112554T1 (el) 2016-02-10
RS51969B (en) 2012-02-29
KR20080094811A (ko) 2008-10-24
RU2431632C2 (ru) 2011-10-20
BRPI0708098A2 (pt) 2011-05-17
PT1992622E (pt) 2011-09-19

Similar Documents

Publication Publication Date Title
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
MY158982A (en) Heterocyclic compound
MY150989A (en) Benzothiazole compounds useful for raf inhibition
WO2009028629A1 (ja) 複素環化合物およびその用途
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
MX342064B (es) Novedoso compuesto de imidazo-oxazina o sal del mismo.
WO2009048101A1 (ja) アミド化合物
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2008019395A3 (en) Compounds for improving learning and memory
WO2009025358A1 (ja) 複素環化合物およびその用途
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
WO2008057775A3 (en) Heterocyclic amide compounds useful as kinase inhibitors
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2010027236A3 (en) Fused heterocyclic compound
WO2008140066A3 (en) Pyridone derivatives as p38a mapk inhibitors
AU2010332955A8 (en) 3,4,4A,10B-tetrahydro-1H-thiopyrano-[4, 3-c] isoquinoline derivatives
GB201305247D0 (en) Amide Compounds
WO2009097515A3 (en) [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
WO2006078984A3 (en) Uses of methylphenidate derivatives
CY1112554T1 (el) Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης
WO2010019203A8 (en) Antifungal agents
IN2014DN04588A (el)